Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]

Clinical trial NCT00404378 · COMPLETED

Trial details

NCT number: NCT00404378
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nausea and Vomiting, Chemotherapy-Induced

Start date: 2006-10-20
Primary completion: 2007-01-05
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.